PURPOSE: The present study is a discovery mode proteomics analysis of the membrane-enriched fraction of postmortem brain tissue from Alzheimer's disease (AD) and control cases. This study aims to validate a method to identify new proteins that could be involved in the pathogenesis of AD and potentially serve as disease biomarkers. EXPERIMENTAL DESIGN: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to analyze the membrane-enriched fraction of human postmortem brain tissue from five AD and five control cases of similar age. Biochemical validation of specific targets was performed by immunoblotting. RESULTS: One thousand seven hundred and nine proteins were identified from the membrane-enriched fraction of frontal cortex. Label-free quantification by spectral counting and G-test analysis identified 13 proteins that were significantly changed in disease. In addition to Tau (MAPT), two additional proteins found to be enriched in AD, ubiquitin carboxy-terminal hydrolase 1 (UCHL1), and syntaxin-binding protein 1 (Munc-18), were validated through immunoblotting. DISCUSSION AND CLINICAL RELEVANCE: Proteomic analysis of the membrane-enriched fraction of postmortem brain tissue identifies proteins biochemically altered in AD. Further analysis of this subproteome may help elucidate mechanisms behind AD pathogenesis and provide new sources of biomarkers.
PURPOSE: The present study is a discovery mode proteomics analysis of the membrane-enriched fraction of postmortem brain tissue from Alzheimer's disease (AD) and control cases. This study aims to validate a method to identify new proteins that could be involved in the pathogenesis of AD and potentially serve as disease biomarkers. EXPERIMENTAL DESIGN: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to analyze the membrane-enriched fraction of human postmortem brain tissue from five AD and five control cases of similar age. Biochemical validation of specific targets was performed by immunoblotting. RESULTS: One thousand seven hundred and nine proteins were identified from the membrane-enriched fraction of frontal cortex. Label-free quantification by spectral counting and G-test analysis identified 13 proteins that were significantly changed in disease. In addition to Tau (MAPT), two additional proteins found to be enriched in AD, ubiquitin carboxy-terminal hydrolase 1 (UCHL1), and syntaxin-binding protein 1 (Munc-18), were validated through immunoblotting. DISCUSSION AND CLINICAL RELEVANCE: Proteomic analysis of the membrane-enriched fraction of postmortem brain tissue identifies proteins biochemically altered in AD. Further analysis of this subproteome may help elucidate mechanisms behind AD pathogenesis and provide new sources of biomarkers.
Authors: Joungil Choi; Allan I Levey; Susan T Weintraub; Howard D Rees; Marla Gearing; Lih-Shen Chin; Lian Li Journal: J Biol Chem Date: 2004-01-13 Impact factor: 5.157
Authors: Stephen B Lewis; Regina Wolper; Yueh-Yun Chi; Lynn Miralia; Yong Wang; Cui Yang; Gerry Shaw Journal: J Neurosci Res Date: 2010-05-15 Impact factor: 4.164
Authors: A Liao; R M Nitsch; S M Greenberg; U Finckh; D Blacker; M Albert; G W Rebeck; T Gomez-Isla; A Clatworthy; G Binetti; C Hock; T Mueller-Thomsen; U Mann; K Zuchowski; U Beisiegel; H Staehelin; J H Growdon; R E Tanzi; B T Hyman Journal: Hum Mol Genet Date: 1998-11 Impact factor: 6.150
Authors: Yair M Gozal; Duc M Duong; Marla Gearing; Dongmei Cheng; John J Hanfelt; Christopher Funderburk; Junmin Peng; James J Lah; Allan I Levey Journal: J Proteome Res Date: 2009-11 Impact factor: 4.466
Authors: Bing Bai; Chadwick M Hales; Ping-Chung Chen; Yair Gozal; Eric B Dammer; Jason J Fritz; Xusheng Wang; Qiangwei Xia; Duc M Duong; Craig Street; Gloria Cantero; Dongmei Cheng; Drew R Jones; Zhiping Wu; Yuxin Li; Ian Diner; Craig J Heilman; Howard D Rees; Hao Wu; Li Lin; Keith E Szulwach; Marla Gearing; Elliott J Mufson; David A Bennett; Thomas J Montine; Nicholas T Seyfried; Thomas S Wingo; Yi E Sun; Peng Jin; John Hanfelt; Donna M Willcock; Allan Levey; James J Lah; Junmin Peng Journal: Proc Natl Acad Sci U S A Date: 2013-09-10 Impact factor: 11.205
Authors: Jozsef Gal; Jing Chen; Yuriko Katsumata; David W Fardo; Wang-Xia Wang; Sergey Artiushin; Douglas Price; Sonya Anderson; Ela Patel; Haining Zhu; Peter T Nelson Journal: J Neuropathol Exp Neurol Date: 2018-01-01 Impact factor: 3.685
Authors: Measho H Abreha; Eric B Dammer; Lingyan Ping; Tian Zhang; Duc M Duong; Marla Gearing; James J Lah; Allan I Levey; Nicholas T Seyfried Journal: Proteomics Date: 2018-10 Impact factor: 3.984
Authors: Benjamin W Henderson; Erik G Gentry; Travis Rush; Juan C Troncoso; Madhav Thambisetty; Thomas J Montine; Jeremy H Herskowitz Journal: J Neurochem Date: 2016-07-01 Impact factor: 5.372
Authors: Jonathan D Cherry; Ahmad Zeineddin; Eric B Dammer; James A Webster; Duc Duong; Nicholas T Seyfried; Allan I Levey; Victor E Alvarez; Bertrand R Huber; Thor D Stein; Patrick T Kiernan; Ann C McKee; James J Lah; Chadwick M Hales Journal: J Neuropathol Exp Neurol Date: 2018-01-01 Impact factor: 3.685